Business Context and Reporting Period
C3is Inc., a foreign private issuer filing on Form 20-F, reported corporate actions for April 2024 in its Form 6-K dated April 12, 2024. The filing concerns a reverse stock split and related adjustments to warrants and Series A Convertible Preferred Stock; it does not present operating or period-end financial results.
Key Financial and Capitalization Metrics
- Effective April 11, 2024, at 11:59 p.m. Eastern time, the company completed a one-for-100 reverse stock split of its common stock.
- Shares issued and outstanding declined from approximately 195.3 million to approximately 1.953 million.
- As of April 11, 2024, 1,953,029 common shares were issued and outstanding.
- The common stock began trading on a split-adjusted basis on Nasdaq Capital Market on April 12, 2024, under the symbol CISS, with new CUSIP Y18284 201.
- No fractional shares were issued; holders otherwise entitled to fractional shares received cash in lieu.
- Outstanding warrants and Series A Convertible Preferred Stock were subject to proportional adjustments to exercise or conversion prices and share quantities.
- The filing provides no revenue, profit, cash flow, margin, debt, liquidity, or other operating-performance metrics.
Material Changes Versus the Prior Comparable Period
The principal material change was the reduction in the number of outstanding common shares through the one-for-100 reverse stock split. The par value and other terms of the common stock were not affected. The filing does not provide a prior-period income statement, balance sheet, cash flow comparison, or operating trend analysis.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
- The filing provides no earnings guidance or business outlook.
- Class B and Class C warrant exercise prices and issuable share quantities may be adjusted further based on the lowest daily volume-weighted average price during the specified adjustment period surrounding the reverse split.
- Class B-1 and Class C-1 warrants include an alternative cashless exercise or exchange option.
- As of April 11, 2024, the outstanding instruments included Class A Warrants for up to 47,650 shares at $105.00 per share; Class B-1 Warrants for up to 87,800 shares at $10.00 per share; Class B-2 Warrants for up to 1,368,500 shares at $10.00 per share; Class C-1 Warrants for up to 358,500 shares at $7.50 per share; and Class C-2 Warrants for up to 1,349,000 shares at $8.50 per share. Certain prices and quantities remain subject to adjustment.
- There were 600,000 Series A Convertible Preferred Shares outstanding, with a $25.00 liquidation preference and a conversion price of $0.03241, subject to adjustment.
Important Facts for Investors to Verify
- Confirm the post-split share count, trading price, new CUSIP, and Nasdaq trading status.
- Review the final post-adjustment exercise prices and share quantities for the Class B and Class C warrants after the adjustment period.
- Assess potential dilution from outstanding warrants and Series A Convertible Preferred Stock.
- Review the attached amendment to the Restated Articles of Incorporation and the warrant terms for the precise adjustment mechanics.
- Consult the company’s periodic financial filings for revenue, profitability, cash flow, debt, liquidity, and going-concern information, which are not provided in this Form 6-K.